News
CING
0.8801
+4.77%
0.0401
Weekly Report: what happened at CING last week (0415-0419)?
Weekly Report · 5d ago
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
Cingulate Inc. Will present at the Planet MicroCap Showcase: VEGAS 2024 conference on Wednesday, May 1, 2024. The biopharmaceutical company will use its drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.
Barchart · 04/16 16:00
Weekly Report: what happened at CING last week (0408-0412)?
Weekly Report · 04/15 09:52
Weekly Report: what happened at CING last week (0401-0405)?
Weekly Report · 04/08 09:54
Cingulate Inc (CING) Receives a Hold from Maxim Group
TipRanks · 04/04 15:05
Cingulate reports Q4 results
Seeking Alpha · 04/01 14:12
*Cingulate Had $52,416 in Cash and Cash Equivalent at Dec 31 >CINGW
Dow Jones · 04/01 12:06
CINGULATE INC - CASH WILL SATISFY OUR CAPITAL NEEDS THROUGH LATE IN Q2 OF 2024
Reuters · 04/01 12:00
Press Release: Cingulate Inc. Reports Fourth -2-
Cingulate Inc. Is a biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Cingulate's initial focus is on the treatment of Attention Deficit/Hyperactivity Disorder.
Dow Jones · 04/01 12:00
Weekly Report: what happened at CING last week (0325-0329)?
Weekly Report · 04/01 09:53
Weekly Report: what happened at CING last week (0318-0322)?
Weekly Report · 03/25 09:55
Cingulate to Participate in Benzinga All Live Access Event
Chairman and CEO Shane Schaffer will participate in a live Benzinga All Access event on March 22, 2024. Cingulate Inc. Is a biopharmaceutical company utilizing its drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.
Barchart · 03/19 15:45
Weekly Report: what happened at CING last week (0311-0315)?
Weekly Report · 03/18 09:54
Weekly Report: what happened at CING last week (0304-0308)?
Weekly Report · 03/11 09:53
Cingulate Inc: Statement of changes in beneficial ownership of securities
Press release · 03/07 10:03
Cingulate to Attend DCAT Week 2024 in New York City
Cingulate Inc. Will be attending DCAT Week March 18-21, 2024, in Midtown Manhattan. Cingulate is a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build a pipeline of next-generation pharmaceutical products.
Barchart · 03/06 05:45
Weekly Report: what happened at CING last week (0226-0301)?
Weekly Report · 03/04 09:54
Weekly Report: what happened at CING last week (0219-0223)?
Weekly Report · 02/26 09:59
More
Webull provides a variety of real-time CING stock news. You can receive the latest news about Cingulate Inc through multiple platforms. This information may help you make smarter investment decisions.
About CING
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.